Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 66357-35-5 | Product Number: R0261
Ranitidine
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- N-[2-[[[5-[(Dimethylamino)methyl]furan-2-yl]methyl]thio]ethyl]-N'-methyl-2-nitroethene-1,1-diamine
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 1G |
134,00 €
|
1 | 15 |
|
| 5G |
465,00 €
|
Contact Us | 20 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | R0261 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__3H__2__2N__4O__3S = 314.40 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 66357-35-5 |
| Reaxys Registry Number | 4845772 |
| MDL Number | MFCD00081180 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 69.0 to 73.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 72 °C |
| Solubility in water | Soluble |
GHS
Related Laws:
| EC Number | 266-332-5 |
| RTECS# | KM6556500 |
Transport Information:
| HS Number | 2932190090 |
Application
Ranitidine: A Histamine H2-Receptor Antagonist
Ranitidine and its hydrochloride [R0073] are histamine H2-receptor antagonists. They have been reported as a potent inhibitors of gastric acid secretion effective in the treatment and prophylaxis of gastrointestinal lesions aggravated by gastric acid secretion. (The product is for research purpose only.)
References
- Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases
- Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases
- Ranitidine (a review on synthesis, physical properties, stability, methods of analysis and pharmacokinetics of ranitidine)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.